FLT3 and acute myeloid leukemia: FMS-like tyrosine kinase 3 (FLT3) mutations, particularly internal tandem duplications (FLT3-ITD), and tyrosine kinase domain (TKD) are among the most common molecular alterations in AML, occurring in approximately 25 to 30% of newly diagnosed patients.